Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Understand when rebalancing triggers capital gains taxes and how to plan for them. This intro highlights key rules and proactive strategies.
23,600 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Equity futures fell and oil surged as the initial round of U.S.-Iran talks began, setting a tense tone for markets an...
Regulators scrutinize exchange activity amid sanction challenges. This article breaks down CoinEx's denial, the fund ...
Zillow, Compass, and MRED filed competing post-hearing briefs after a two-day Chicago hearing on data feeds. A judge ...
A director’s stock sale can spark worry, but not every insider move is a warning. This guide shows how to assess trad...
A close look at on-chain data shows Vitalik Buterin holding roughly 240,000 ETH, with recent large withdrawals and a ...
Nvidia’s Jens en Huang just signaled a potential pivot into software stocks as AI optimism hits a softer patch. This ...
A single moment can ripple through your wallet. When Lionel Messi stood beside a world leader at a White House event,...
A seasoned strategist released a clockwork model to estimate how long the Iran conflict could endure, tying escalatio...
NYSE has posted a listing for MSBT, a potential Morgan Stanley Bitcoin Trust. Market watchers say the bank’s first ba...
President Trump pushes to suspend the federal gas tax to lower pump prices, but analysts say higher oil prices and fu...
A drone strike sparks fire near the UAE's Barakah nuclear plant, prompting swift emergency action. Officials say safe...